Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Orchard Therapeutics

    NASDAQ: ORTX · Real-Time Price · USD
    16.70
    0.05 (0.30%)
    At close: Jan 23, 2024, 10:00 PM

    Orchard Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 6.99M 483K
    Cost of Revenue
    		 2.43M 226K
    Gross Profit
    		 4.55M 257K
    Operating Income
    		 -31.59M -36.41M
    Interest Income
    		 857K 63K
    Pretax Income
    		 -9.01M -36.22M
    Net Income
    		 -7.88M -36.35M
    Selling & General & Admin
    		 10.6M 13.55M
    Research & Development
    		 25.55M 23.35M
    Other Expenses
    		 n/a n/a
    Operating Expenses
    		 36.15M 36.9M
    Interest Expense
    		 933K 683K
    Selling & Marketing Expenses
    		 4.13M 5.26M
    Cost & Expenses
    		 38.58M 36.9M
    Income Tax Expense
    		 -1.13M 125K
    Shares Outstanding (Basic)
    		 12.8M 12.4M
    Shares Outstanding (Diluted)
    		 12.82M 12.4M
    EPS (Basic)
    		 -0.61 -2.93
    EPS (Diluted)
    		 -0.61 -2.93
    EBITDA
    		 -8.08M -35.54M
    EBIT
    		 -150.9M -141.47M
    Depreciation & Amortization
    		 23.51M 874K

    Add to Watchlist